Urology · Wilmington, NC
NPI
1730173287
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1905 Glen Meade Rd
Wilmington, NC, 28403
Phone (910) 763-6251
Groups this clinician bills Medicare through
Medicare paid, 2024
$870K
20,494 services
Medicare patients, 2024
1,106
Average age 77
Drug cost, 2024
$8.5M
2,816 prescriptions
Company payments, 2025
$3,169
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter A Zeman was code J1952 (leuprolide injectable, camcevi, 1 mg), 2,268 times for 33 patients. In total Peter A Zeman billed 20,494 services in 98 codes, and Medicare paid $870K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 2,268 | 33 | $43.65 | $99K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,701 | 16 | $0.10 | $172 |
| 81002 Clinical Chemistry | Office | 1,267 | 846 | $3.39 | $4,294 |
| 99214 Office E&M - Established | Office | 1,266 | 827 | $82.03 | $104K |
| 84153 Clinical Chemistry | Office | 699 | 510 | $17.72 | $12K |
| 36415 Venipuncture Blood Collection | Office | 693 | 504 | $8.55 | $5,924 |
| 84311 Immunoassay | Office | 384 | 190 | $7.83 | $3,008 |
| 51798 Ultrasound - Nonspecific | Office | 372 | 269 | $7.60 | $2,828 |
| 99215 Office E&M - Established | Office | 256 | 217 | $121.81 | $31K |
| 99213 Office E&M - Established | Office | 250 | 206 | $57.56 | $14K |
| 52000 Cystourethroscopy | Office | 214 | 191 | $170.61 | $37K |
| 82247 Clinical Chemistry | Office | 192 | 190 | $4.85 | $932 |
| 82010 Clinical Chemistry | Office | 192 | 190 | $7.90 | $1,518 |
| 82043 Clinical Chemistry | Office | 192 | 190 | $5.60 | $1,075 |
| 82945 Clinical Chemistry | Office | 192 | 190 | $3.80 | $729 |
By year: 2022 $992K for 17,950 services; 2023 $768K for 19,271 services; 2024 $870K for 20,494 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 1,267 | 846 | $3.39 | $4,294 |
| 84153 Clinical Chemistry | 699 | 510 | $17.72 | $12K |
| 36415 Venipuncture Blood Collection | 693 | 504 | $8.55 | $5,924 |
| 84311 Immunoassay | 384 | 190 | $7.83 | $3,008 |
| 83069 Blood Count | 192 | 190 | $3.82 | $733 |
| 84156 Clinical Chemistry | 192 | 190 | $3.55 | $682 |
| 82945 Clinical Chemistry | 192 | 190 | $3.80 | $729 |
| 82010 Clinical Chemistry | 192 | 190 | $7.90 | $1,518 |
| 82043 Clinical Chemistry | 192 | 190 | $5.60 | $1,075 |
| 82247 Clinical Chemistry | 192 | 190 | $4.85 | $932 |
Medicare prescription drug claims, 2024
In 2024, the drug Peter A Zeman prescribed most often to Medicare patients was Tamsulosin Hcl, with 873 prescriptions and refills. In total Peter A Zeman wrote 2,816 Medicare prescriptions that cost $8.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 873 | 2,356 | 272 | $17K |
| Xtandi Enzalutamide | 482 | 482 | 57 | $6.5M |
| Finasteride Generic | 291 | 841 | 90 | $4,007 |
| Orgovyx Relugolix | 136 | 136 | 16 | $347K |
| Ciprofloxacin Hcl Generic | 108 | 114 | 79 | $625 |
| Abiraterone Acetate Generic | 100 | 100 | 15 | $160K |
| Testosterone Cypionate Generic | 95 | 178 | 23 | $3,882 |
| Gemtesa Vibegron | 72 | 154 | 20 | $72K |
| Trelstar Triptorelin Pamoate | 62 | 340 | 38 | $295K |
| Myrbetriq Mirabegron | 52 | 96 | 13 | $41K |
| Prednisone Generic | 50 | 88 | 11 | $561 |
| Erleada Apalutamide | 45 | 45 | Under 11 | $636K |
| Silodosin Generic | 41 | 110 | 16 | $3,140 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 39 | 50 | 24 | $333 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 39 | 103 | 14 | $1,177 |
Brand drugs: 888 claims; generic drugs: 1,928 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter A Zeman $3,169 ($3,169 in general payments such as food, travel and fees) from 27 companies. The largest payer was Dendreon Pharmaceuticals LLC with $991.
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 34 | $991 |
| Sumitomo Pharma America, Inc. 4506.T | 18 | $359 |
| Pfizer Inc. PFE | 12 | $263 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $240 |
| Endo USA, Inc. | 10 | $154 |
| Abbvie Inc. ABBV | 9 | $152 |
| Coloplast Corp | 4 | $114 |
| Astellas Pharma US Inc 4503.T | 5 | $102 |
| Janssen Biotech, Inc. JNJ | 4 | $86.73 |
| Verity Pharmaceuticals Inc. | 4 | $71.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.